Advance Gout Treatment Research

Empowering Patients, Shaping Futures

Join our research study and contribute to advancing Gout treatment. Experience cutting-edge care at no cost and receive compensation. Together, we can shape the future of Gout management.

GET YOUR

FREE CONSULTATION

Fill out this form to see if you Qualify!

Discover Our Mission: Transforming Gout Treatment Together

RID Gout Study is a pioneering research initiative aimed at revolutionizing Gout treatment. We're committed to exploring the potential of an investigational drug, offering participants access to top-tier medical care at no cost. Our dedicated team of physicians and researchers is passionate about improving patient outcomes and advancing medical science. Join us in shaping the future of Gout management

Transforming Lives: Your Participation Fuels Progress

Join the RID Gout Study and experience the potential of an investigational drug for Gout at no cost. Participants may be compensated for their time and travel per visit and contribute to advancing medical science. Benefit from the care of a dedicated team of professionals, all while helping to shape the future of Gout treatment.

Joining the RID Gout Study has been a game-changer for me. The care team is incredibly supportive, and the potential of the investigational drug is promising.

Amily Thompsan

Participant, RID Gout Study

Participating in the study has given me hope. The compensation is a bonus, but contributing to Gout treatment advancement is the real reward.

Rose Rodman

Volunteer, Health Research Advocacy

The RID Gout Study is professionally managed and participant-friendly. It's an opportunity to be part of something bigger, something that could change lives.

Robert Johnson

Member, Patient Rights Organization

Understanding Gout: Could You Be Our Next Participant?

The RID Gout Study welcomes participants aged between 18 and 75 who are diagnosed with Gout and have not responded well to existing treatments. Gout is a form of inflammatory arthritis that develops in people with high uric acid levels in the body. It often results in severe pain, redness, and swelling in joints, particularly the big toe. By participating in our study, you could contribute to the development of a potentially more effective treatment for this condition.

Meet the Dr.

Dr. Dennis J. Levinson

Chief Principal Investigator

Dr. Dennis J. Levinson is a Clinical Associate Professor of Medicine at the University of Illinois, Chicago. He received his undergraduate education at the University of Illinois and attended the Rosalind Franklin University (formerly Chicago Medical School). After completing his residency at Michael Reese Hospital and serving in the military, he finished his fellowship in rheumatology at the University of Chicago.

Dr. Levinson has been practicing rheumatology for 40 years. He is board certified in Internal Medicine and Rheumatology, and a Founding Fellow of the American College of Rheumatology. He is a past president of the Chicago Rheumatism Society and served as Chief of Service and Program Director of Internal Medicine at Michael Reese Hospital in Chicago from 1999 to 2008. He currently sits on the board of the Michael Reese Research and Education Foundation, which focuses on funding scholarships, community healthcare, and research.

Dr. Levinson has contributed to the medical literature with over 74 articles, abstracts and book chapters and continues to participate in clinical research. He was also involved in the first stem cell transplant for sickle cell disease in the Chicago area. In 2016, he received the Hispanocare Outstanding Community Award for scholarship support in the Latino community.

Our Comprehensive Services

Experience the potential of a new investigational drug aimed at effectively managing Gout symptoms..

Receive top-tier care from our team of dedicated physicians, nurses, and study staff throughout the study.

Participants may be compensated for their time and travel as a token of our appreciation for your invaluable contribution.

FREQUENTLY ASKED QUESTION

How does the RID Gout Study contribute to the future of Gout treatment?

The RID Gout Study is exploring the potential of an investigational drug that could revolutionize Gout treatment. Your participation helps us gather crucial data to evaluate its effectiveness.

What is the time commitment for participating in the RID Gout Study?

The study spans about 32 weeks, with participants visiting a study center approximately 14 times. The frequency of visits ensures thorough monitoring of the investigational drug's effects.

How does the RID Gout Study ensure the safety of its participants?

Participant safety is our top priority. The study is conducted under the supervision of a dedicated team of physicians and nurses, ensuring all protocols are strictly followed.

09:00 AM to 05:00 PM

Monday to Friday

Off

Sign Up and Begin Your Journey Toward Relief

(773) 786-9002

Advanced Quality Medical Research: 10 Orland Square Dr.,

Orland Park, IL 60462